Digital Respiratory Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

Online Pharmacies is the fastest growing sector, North America is the largest market

The Global Digital Respiratory Devices Market is set for substantial growth, projected to increase from USD 44.98 Billion in 2025 to USD 81.09 Billion by 2031, achieving a 10.32% CAGR. This market includes smart inhalers, nebulizers, and spirometers that integrate sensors and connectivity to monitor medication adherence and lung physiology. Key drivers include the rising prevalence of chronic respiratory conditions and the growing demand for remote patient monitoring, which facilitates timely medical interventions.

In 2025, chronic respiratory diseases affected 81.7 million people in the WHO European Region, highlighting the critical need for advanced management tools. However, significant challenges like the high cost of developing and acquiring these connected technologies, coupled with limited reimbursement frameworks, could hinder market expansion, making these devices unaffordable for many and restricting their adoption in regions with limited healthcare funding. This financial barrier remains a major obstacle to widespread global implementation.

Market Drivers

The increasing global incidence of asthma and COPD is a primary driver for the Digital Respiratory Devices Market, creating a strong demand for advanced disease management tools like smart inhalers to prevent exacerbations. This demand is further amplified by worsening environmental conditions; for instance, 131 million people in the U.S. live with unhealthy air pollution levels, increasing respiratory risks. Concurrently, the rise of remote patient monitoring (RPM) and telehealth solutions is transforming care delivery by enabling real-time data transmission via IoT connectivity, allowing personalized treatment adjustments without frequent hospital visits. This shift facilitates proactive interventions, improving patient adherence and clinical outcomes. The widespread adoption of connected devices, with over 26 million deployed globally by ResMed, underscores the established infrastructure for value-based care, making digital respiratory devices integral to modern medicine.

Market Challenges

A major impediment to market expansion is the substantial capital required for the development and procurement of connected respiratory technologies. Manufacturers face high research and engineering costs, which translate into elevated retail prices for smart inhalers and monitoring devices. Furthermore, the lack of comprehensive reimbursement policies in many regions forces patients to pay out-of-pocket, making these advanced solutions difficult for healthcare systems, especially in economically constrained areas, to justify over less expensive traditional alternatives. This economic barrier directly limits the uptake and market penetration of digital solutions, exacerbating the already high financial strain on patients with respiratory conditions. For example, asthma patients incurred annual medical expenses $3,266 higher than individuals without the condition in 2025, making the additional cost of unsubsidized digital devices prohibitive and stalling global market growth.

Market Trends

Strategic collaborations between pharmaceutical companies and medical technology firms are fundamentally reshaping the market by moving towards co-development models that bundle medication with digital connectivity. These partnerships allow pharmaceutical companies to utilize sensor technologies for enhanced adherence tracking, while device manufacturers gain access to broader patient networks and distribution channels.

This synergistic approach validates the commercial viability of connected ecosystems, as evidenced by companies like Adherium, which surpassed its 2025 shipment milestones by delivering 4,666 connected devices, confirming rising demand for integrated monitoring solutions. Simultaneously, the development of eco-friendly and sustainable device designs is gaining significant momentum. This trend is driven by increasing regulatory pressure to decarbonize respiratory care, leading to the engineering of inhalers with low-global-warming-potential propellants and reusable components. Corporations are actively investing in green innovation to align with global ESG mandates, with Chiesi Farmaceutici, for example, developing a Carbon Minimal Inhaler designed to reduce propellant gas emissions by up to 90% compared to traditional devices.

Key Market Players

• COHERO Health Inc.
• Cognita Labs llc
• Adherium Limited
• Amiko Digital Health Limited
• Teva Pharmaceuticals Industries Ltd.
• Propeller Health
• Novartis AG
• Pneuma Respiratory Inc.
• 3M Health Care Limited
• AireHealth, Inc.

Report Scope

In this report, the Global Digital Respiratory Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital Respiratory Devices Market, by Product:

• Smart Inhalers & Nebulizers
• Sensors & Apps
• Others

Digital Respiratory Devices Market, by Indication:

• Asthma
• COPD
• Others

Digital Respiratory Devices Market, by Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Digital Respiratory Devices Market, by Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Respiratory Devices Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.